MetLife Investment Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-23,791
| Closed | -$1.79M | – | 2874 |
|
|
2022
Q2 | $1.79M | Sell |
23,791
-1,747
| -7% | -$131K | 0.01% | 942 |
|
|
2022
Q1 | $686K | Buy |
25,538
+9,050
| +55% | +$243K | ﹤0.01% | 1575 |
|
|
2021
Q4 | $786K | Hold |
16,488
| – | – | 0.01% | 1241 |
|
|
2021
Q3 | $1.1M | Hold |
16,488
| – | – | 0.01% | 1076 |
|
|
2021
Q2 | $1.29M | Buy |
16,488
+2,103
| +15% | +$164K | 0.01% | 1045 |
|
|
2021
Q1 | $1.36M | Sell |
14,385
-875
| -6% | -$82.8K | 0.01% | 996 |
|
|
2020
Q4 | $1.86M | Buy |
15,260
+857
| +6% | +$104K | 0.02% | 864 |
|
|
2020
Q3 | $1.26M | Buy |
14,403
+2,289
| +19% | +$200K | 0.01% | 930 |
|
|
2020
Q2 | $782K | Hold |
12,114
| – | – | 0.01% | 1134 |
|
|
2020
Q1 | $541K | Hold |
12,114
| – | – | 0.01% | 1177 |
|
|
2019
Q4 | $755K | Buy |
12,114
+7,718
| +176% | +$481K | 0.01% | 1239 |
|
|
2019
Q3 | $165K | Hold |
4,396
| – | – | ﹤0.01% | 2051 |
|
|
2019
Q2 | $179K | Buy |
+4,396
| New | +$179K | ﹤0.01% | 2096 |
|